follitropin beta (Follistim)
follitropin beta is an FDA-licensed reference biologic from Organon USA Inc., a subsidiary of Merck & Co., Inc..
Reference product
Follistim follitropin beta
Organon USA Inc., a subsidiary of Merck & Co., Inc.
View full reference-product record- Approved
- Marketing
- Disc
- Center
- CDER
- Patents
- None listed
Molecular structure
Experimental 3D structure for follitropin beta from the RCSB Protein Data Bank (PDB 1FL7).
Interactive biological assembly from PDB entry 1FL7. Drag to rotate, scroll to zoom, and inspect the full atomic structure right here, with no need to leave the page.
Exclusivity & patent cliffs
Reference approval
Approval date of the reference follitropin beta product.
29 yr 5 mo ago
follitropin beta: frequently asked questions
Reference exclusivity, biosimilars, interchangeability, and patents for this molecule, from the FDA Purple Book.
Built from official FDA Purple Book records (monthly downloads, the Advanced Search interface, and the published Patent List), with reference-product, license-type, and exclusivity context for follitropin beta.
Related FDA reference tools
- FDA Orange BookApproved drugs, generics, therapeutic-equivalence codes, patents, and exclusivity.
- FDA BiosimilarsFDA-approved biosimilars and interchangeable biosimilars, by reference product.
- 510(k) Predicate DatabaseSearch FDA 510(k) clearances and map predicate-device lineage.
- FDA 483 DatabaseFDA Form 483 observations and inspection records by firm, date, and citation.
